KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to $129.8 million.

  • Supernus Pharmaceuticals' Short-term Investments fell 6506.7% to $129.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.8 million, marking a year-over-year decrease of 6506.7%. This contributed to the annual value of $384.3 million for FY2024, which is 11370.31% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Short-term Investments of $129.8 million as of Q3 2025, which was down 6506.7% from $377.9 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Short-term Investments ranged from a high of $384.3 million in Q4 2024 and a low of $105.2 million during Q3 2023
  • In the last 5 years, Supernus Pharmaceuticals' Short-term Investments had a median value of $196.5 million in 2022 and averaged $233.8 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 25315.86% in 2024, then crashed by 6506.7% in 2025.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Short-term Investments stood at $136.2 million in 2021, then soared by 170.26% to $368.2 million in 2022, then crashed by 51.16% to $179.8 million in 2023, then surged by 113.7% to $384.3 million in 2024, then tumbled by 66.23% to $129.8 million in 2025.
  • Its Short-term Investments stands at $129.8 million for Q3 2025, versus $377.9 million for Q2 2025 and $347.7 million for Q1 2025.